First translational research engine available
investigators the ability to integrate clinical data from a number
of different sources across the clinical development spectrum.
According to the firm that makes the software, RemedyMD, this will be the industry's first translational research engine and will "dramatically improve the efficiency of clinical investigators."
Called Translate, it uses the firm's patent-pending 'SMART' interfaces to gather and reconcile clinical data from various electronic health information systems and gathers them together into a centralised, researchable data repository.
"The need to aggregate data from multiple sources has been limiting the efficiency of clinical researchers," said RemedyMD's CMO Dr. Roberto Rocha.
Translate also facilitates predictive outcomes tracking and retrospective data analysis, said the company.
According to Gary Kennedy, chairman and CEO of RemedyMD, outcome tracking has particularly become a major focus in clinical research in recent years and Translate was designed specifically for the needs associated with these studies.
It is a web-based solution and supports and integrates all research activities, from study protocol creation to data analysis and publication.
"By using Translate, clinical investigators can streamline communication among study participants, collaborate with other researchers, and significantly decrease the effort required to set up and manage a clinical research study," said the firm.
"As a result they can spend less time micromanaging data and study details and more time focusing on patients, disease pathways and treatment regimens."
